Cost effectiveness and projected national impact of colorectal cancer screening in France

Cesare Hassan; R. Benamouzig; Cristiano Spada; T. Ponchon; A. Zullo; J. C. Saurin; Guido Costamagna

doi:10.1055/s-0030-1256409

Cost effectiveness and projected national impact of colorectal cancer screening in France

Cesare Hassan
, R. Benamouzig
, Cristiano Spada
, T. Ponchon
, A. Zullo
, J. C. Saurin
, Guido Costamagna

Hôpital Avicenne
Hôpital Édouard Herriot

Risultato della ricerca: Contributo in rivista › Articolo

46 Citazioni (Scopus)

Abstract

Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.

Lingua originale	Inglese
pagine (da-a)	780-793
Numero di pagine	14
Rivista	Endoscopy
Volume	43
DOI	https://doi.org/10.1055/s-0030-1256409
Stato di pubblicazione	Pubblicato - 2011

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Capsule Endoscopy
Colonoscopy
Colorectal Neoplasms
Computer Simulation
Cost-Benefit Analysis
France
Humans
Markov Chains
Mass Screening
Occult Blood
Sigmoidoscopy

Accesso al documento

10.1055/s-0030-1256409

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{e9fc992f54b54c1192bf47b3ee2ae893,

title = "Cost effectiveness and projected national impact of colorectal cancer screening in France",

abstract = "Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.",

keywords = "Capsule Endoscopy, Colonoscopy, Colorectal Neoplasms, Computer Simulation, Cost-Benefit Analysis, France, Humans, Markov Chains, Mass Screening, Occult Blood, Sigmoidoscopy, Capsule Endoscopy, Colonoscopy, Colorectal Neoplasms, Computer Simulation, Cost-Benefit Analysis, France, Humans, Markov Chains, Mass Screening, Occult Blood, Sigmoidoscopy",

author = "Cesare Hassan and R. Benamouzig and Cristiano Spada and T. Ponchon and A. Zullo and Saurin, \{J. C.\} and Guido Costamagna",

year = "2011",

doi = "10.1055/s-0030-1256409",

language = "English",

volume = "43",

pages = "780--793",

journal = "Endoscopy",

issn = "1438-8812",

publisher = "Georg Thieme Verlag",

}

TY - JOUR

T1 - Cost effectiveness and projected national impact of colorectal cancer screening in France

AU - Hassan, Cesare

AU - Benamouzig, R.

AU - Spada, Cristiano

AU - Ponchon, T.

AU - Zullo, A.

AU - Saurin, J. C.

AU - Costamagna, Guido

PY - 2011

Y1 - 2011

N2 - Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.

AB - Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.

KW - Capsule Endoscopy

KW - Colonoscopy

KW - Colorectal Neoplasms

KW - Computer Simulation

KW - Cost-Benefit Analysis

KW - France

KW - Humans

KW - Markov Chains

KW - Mass Screening

KW - Occult Blood

KW - Sigmoidoscopy

KW - Capsule Endoscopy

KW - Colonoscopy

KW - Colorectal Neoplasms

KW - Computer Simulation

KW - Cost-Benefit Analysis

KW - France

KW - Humans

KW - Markov Chains

KW - Mass Screening

KW - Occult Blood

KW - Sigmoidoscopy

UR - http://hdl.handle.net/10807/5979

U2 - 10.1055/s-0030-1256409

DO - 10.1055/s-0030-1256409

M3 - Article

SN - 1438-8812

VL - 43

SP - 780

EP - 793

JO - Endoscopy

JF - Endoscopy

ER -

Cost effectiveness and projected national impact of colorectal cancer screening in France

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo